EDGAR Filing Documents for 0001279569-11-000476

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001279569-11-000476

Filing Date

2011-04-12

Accepted

2011-04-12 13:51:34

Documents

Period of Report

2011-02-28

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	lorus6k.htm	6-K	15873
2	Q3 INTERIM FINANCIAL STATEMENTS	ex991.htm	EX-99.1	540314
3	Q3 MANAGEMENT DISCUSSION AND ANALYSIS	ex992.htm	EX-99.2	179974
4	CEO/CFO CERTIFICATES	ex993.htm	EX-99.3	35137
	Complete submission text file	0001279569-11-000476.txt		772519

Mailing Address 2 MERIDIAN ROAD TORONTO A6 M9W 4Z7

Business Address 2 MERIDIAN ROAD . TORONTO A6 M9W 4Z7

LORUS THERAPEUTICS INC (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-32001 | Film No.: 11754509
SIC: 2836 Biological Products, (No Diagnostic Substances)